PAVM Valuation

PAVmed Inc

Add to Watchlist

Advanced Chart

0.429

+0.006(1.420%)1D

PAVM Relative Valuation

PAVM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, PAVM is overvalued; if below, it's undervalued.

Historical Valuation

PAVmed Inc (PAVM) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.43 is considered Undervalued compared with the five-year average of -2.87. The fair price of PAVmed Inc (PAVM) is between 8.32 to 55.12 according to relative valuation methord. Compared to the current price of 0.43 USD , PAVmed Inc is Undervalued By 94.84%.

Relative Value

Fair Zone

8.32-55.12

Current Price：0.43

94.84%

Undervalued

-0.54

Trailing

Forward

-1.73

EV/EBITDA

PAVmed Inc. (PAVM) has a current EV/EBITDA of -1.73. The 5-year average EV/EBITDA is -3.42. The thresholds are as follows: Strongly Undervalued below -10.43, Undervalued between -10.43 and -6.92, Fairly Valued between 0.08 and -6.92, Overvalued between 0.08 and 3.58, and Strongly Overvalued above 3.58. The current Forward EV/EBITDA of -1.73 falls within the Historic Trend Line -Fairly Valued range.

-1.37

EV/EBIT

PAVmed Inc. (PAVM) has a current EV/EBIT of -1.37. The 5-year average EV/EBIT is -3.25. The thresholds are as follows: Strongly Undervalued below -11.61, Undervalued between -11.61 and -7.43, Fairly Valued between 0.93 and -7.43, Overvalued between 0.93 and 5.12, and Strongly Overvalued above 5.12. The current Forward EV/EBIT of -1.37 falls within the Historic Trend Line -Fairly Valued range.

0.43

PAVmed Inc. (PAVM) has a current PS of 0.43. The 5-year average PS is 64.31. The thresholds are as follows: Strongly Undervalued below -144.07, Undervalued between -144.07 and -39.88, Fairly Valued between 168.49 and -39.88, Overvalued between 168.49 and 272.68, and Strongly Overvalued above 272.68. The current Forward PS of 0.43 falls within the Historic Trend Line -Fairly Valued range.

-0.48

P/OCF

PAVmed Inc. (PAVM) has a current P/OCF of -0.48. The 5-year average P/OCF is -5.74. The thresholds are as follows: Strongly Undervalued below -32.87, Undervalued between -32.87 and -19.30, Fairly Valued between 7.83 and -19.30, Overvalued between 7.83 and 21.40, and Strongly Overvalued above 21.40. The current Forward P/OCF of -0.48 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/FCF

PAVmed Inc. (PAVM) has a current P/FCF of 0.00. The 5-year average P/FCF is -2.74. The thresholds are as follows: Strongly Undervalued below -12.69, Undervalued between -12.69 and -7.72, Fairly Valued between 2.23 and -7.72, Overvalued between 2.23 and 7.20, and Strongly Overvalued above 7.20. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

PAVmed Inc (PAVM) has a current Price-to-Book (P/B) ratio of 0.67. Compared to its 3-year average P/B ratio of -0.16 , the current P/B ratio is approximately -520.06% higher. Relative to its 5-year average P/B ratio of -13.69, the current P/B ratio is about -104.87% higher. PAVmed Inc (PAVM) has a Forward Free Cash Flow (FCF) yield of approximately -1.21%. Compared to its 3-year average FCF yield of -275.51%, the current FCF yield is approximately -99.56% lower. Relative to its 5-year average FCF yield of -174.67% , the current FCF yield is about -99.30% lower.

0.67

P/B

Median3y

-0.16

Median5y

-13.69

-1.21

FCF Yield

Median3y

-275.51

Median5y

-174.67

Competitors Valuation Multiple

The average P/S ratio for PAVM's competitors is 1.55, providing a benchmark for relative valuation. PAVmed Inc Corp (PAVM) exhibits a P/S ratio of 0.43, which is -72.27% above the industry average. Given its robust revenue growth of -99.39%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Strata Skin Sciences Inc

Performance Decomposition

Market capitalization of PAVM decreased by 55.78% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -1.52K to -205.40K.

The secondary factor is the Revenue Growth, contributed -99.39%to the performance.

Overall, the performance of PAVM in the past 1 year is driven by Margin Expansion. Which is more sustainable.

-99.39%

979.00K → 6.00K

Revenue Growth

13383.09%

-1.52K → -205.40K

Margin Expansion

-13339.48%

0.00 → 0.52

P/E Change

-55.78%